KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Cash from Financing Activities (2018 - 2025)

Progyny (PGNY) has disclosed Cash from Financing Activities for 8 consecutive years, with $154.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities changed N/A to $154.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$75.2 million, a N/A change, with the full-year FY2025 number at -$99.4 million, up 67.94% from a year prior.
  • Cash from Financing Activities was $154.2 million for Q4 2025 at Progyny, up from -$3.3 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $154.2 million in Q4 2025 to a low of -$162.8 million in Q2 2024.
  • A 5-year average of -$8.0 million and a median of -$2.8 million in 2022 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: crashed 8752.04% in 2024, then skyrocketed 88.0% in 2025.
  • Progyny's Cash from Financing Activities stood at -$3.3 million in 2021, then increased by 15.93% to -$2.8 million in 2022, then tumbled by 80.37% to -$5.0 million in 2023, then crashed by 1160.76% to -$63.4 million in 2024, then soared by 343.38% to $154.2 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Cash from Financing Activities are $154.2 million (Q4 2025), -$3.3 million (Q1 2025), and -$63.4 million (Q3 2024).